en English
en Englishfr Frenchde Germanit Italianru Russianes Spanish

Midday movers: Boeing flies, Alphabet flops, and more

Midday movers: Boeing flies, Alphabet flops, and more By Investing.com

Breaking News

‘;

AuthorPeter NurseStock Markets

Published Jan 31, 2024 07:34AM ET
Updated Jan 31, 2024 11:32AM ET

© Reuters

(Updated – January 31, 2024 11:29 AM EST)

Investing.com — U.S. futures traded lower Wednesday as investors digested earnings from some tech giants ahead of the conclusion of the latest Federal Reserve policy-setting meeting.

Here are some of the biggest U.S. stock movers today:

Alphabet (NASDAQ:GOOGL) stock slumped 6.4% after the Google-parent reported holiday-season advertising sales below expectations and projected higher spending this year on artificial intelligence.

Microsoft (NASDAQ:MSFT) stock fell 1% after the software giant forecast rising costs to develop new artificial-intelligence features, eclipsing a quarterly results beat.

Tesla (NASDAQ:TSLA) stock fell 0.2% after a U.S. judge voided CEO Elon Musk’s record-breaking $56 billion pay package.

Starbucks (NASDAQ:SBUX) shares were volatile after the coffee chain cut its annual sales forecast, warning of softer demand in January and a slow recovery in China. However, even more weakness had been expected following disappointing store traffic in November and December. The stock was flat midday after earlier rising 3%.

AMD (NASDAQ:AMD) stock fell 3.4% after the chipmaker’s first-quarter revenue forecast and a boosted projection for AI processors failed to meet expectations.

Mondelez (NASDAQ:MDLZ) stock fell 1.7% after the Carbiry parent posted a rise in fourth-quarter sales on Tuesday, but price hikes took a toll on volumes as it squeezed demand.

Thermo Fisher (NYSE:TMO) stock fell 3.3% after the medical equipment maker forecast annual profit and revenue below expectations, signaling a slump in demand for its services.

Novo Nordisk (NYSE:NVO) stock rose 4.8% after the Danish drugmaker forecast another year of double-digit growth due to the popularity of its weight-loss drug Wegovy.

Boeing (NYSE:BA) stock rose 6.5% after reporting a smaller than expected loss in the fourth quarter. The embattled aircraft manufacturer also postponed 2024 outlook, with CEO Dave Calhoun saying the company faces a “serious challenge.”

Cigna (NYSE:CI) stock rose 1% after the health insurer agreed to sell its Medicare business to Health Care Service Corp for $3.3 billion in cash.

Rockwell Automation (NYSE:ROK) stock fell 15% after missing first quarter EPS and revenue estimates, fueling doubts about full-year growth.

Stryker (NYSE:SYK) climbed 6% after reporting better than expected earnings and revenue in the fourth quarter. The medical device company’s strong performance prompted analysts to upgrade the stock’s rating to ‘buy’, while more than a half dozen others increased their price targets.

Edwards Lifesciences (NYSE:EW) climbed 6.3% and Zimmer Biomet (ZBH) climbed 3% following strong results from Stryker and Boston Scientific (NYSE:BSX). Boston Scientific was higher by 2.6%.

New York Community Bancorp (NYSE:NYCB) declined 35% after it surprised investors with a larger than expected provision for credit losses and a dividend cut. Weakness in NYCB weighed on other regional banks, causing a related ETF (KRE) to decline 3.6%.

Additional reporting by Louis Juricic

Midday movers: Boeing flies, Alphabet flops, and more

Our Apps



Terms And Conditions
Privacy Policy
Risk Warning
Do not sell my personal information

© 2007-2024 Fusion Media Limited. All Rights Reserved.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Fed’s Powell sees lower rates on the horizon as inflation ebbs, economy bounces ahead
Next post SEC’s New Era for SPACs: Tightening Rules Amid Market Realities